Literature DB >> 17194443

Obesity-induced upregulation of myocardial endothelin-1 expression is mediated by leptin.

Suko Adiarto1, Noriaki Emoto, Naoko Iwasa, Mitsuhiro Yokoyama.   

Abstract

Several studies have shown that leptin, the product of the obese gene, may link obesity with cardiovascular diseases, and in particular with cardiac hypertrophy. In vitro studies suggest that the mechanism by which leptin causes cardiac hypertrophy involves the upregulation of endogenous endothelin-1 (ET-1), a potent vasoconstrictor and mitogen. Whether obesity-associated hyperleptinemia causes an increase in myocardial ET-1 expression in vivo remains unclear. To address this issue, we fed mice with a high-fat diet and analyzed serum levels of ET-1 and ET-1 mRNA in the heart. We found that in mice fed a high-fat diet, serum ET-1, myocardial ET-1, leptin and leptin receptor mRNA were all elevated. In contrast, in leptin-deficient obese (ob/ob) mice, both serum and myocardial ET-1 levels were not higher than in wild type mice. These findings suggest that upregulation of myocardial ET-1 by obesity is mediated by leptin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194443     DOI: 10.1016/j.bbrc.2006.12.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Endothelial overexpression of endothelin-1 modulates aortic, carotid, iliac and renal arterial responses in obese mice.

Authors:  Oliver Baretella; Sookja K Chung; Aimin Xu; Paul M Vanhoutte
Journal:  Acta Pharmacol Sin       Date:  2017-02-20       Impact factor: 6.150

2.  Paradoxical lack of increase in endothelin-1 levels in obese mice - possible role of endothelin-B receptors.

Authors:  Oliver Baretella; Sookja K Chung; Aimin Xu; Paul M Vanhoutte
Journal:  Acta Pharmacol Sin       Date:  2017-11-09       Impact factor: 6.150

Review 3.  Endothelin-1 in the pathophysiology of obesity and insulin resistance.

Authors:  Haley N Jenkins; Osvaldo Rivera-Gonzalez; Yann Gibert; Joshua S Speed
Journal:  Obes Rev       Date:  2020-07-06       Impact factor: 9.213

4.  Artificial cold wave-induced cerebral infarction in rats with carotid atherosclerosis.

Authors:  Zhen-Yu Tang; Qiu-Yan Zhu; Li-Jun Xu; Li-Ying Deng; Ying Zeng; Wei-Jiang Ding; Wei Huang
Journal:  J Mol Neurosci       Date:  2012-03-14       Impact factor: 3.444

Review 5.  The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism.

Authors:  Yukang Mao; Kun Zhao; Peng Li; Yanhui Sheng
Journal:  Mol Cell Biochem       Date:  2022-10-10       Impact factor: 3.842

Review 6.  Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.

Authors:  Michele Cavalera; Junhong Wang; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

7.  Obesity and airway responsiveness: role of TNFR2.

Authors:  Alison S Williams; Lucas Chen; David I Kasahara; Huiqing Si; Allison P Wurmbrand; Stephanie A Shore
Journal:  Pulm Pharmacol Ther       Date:  2012-05-11       Impact factor: 3.410

Review 8.  Immune Mechanisms Linking Obesity and Preeclampsia.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Biomolecules       Date:  2015-11-12

Review 9.  Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases.

Authors:  Lucia Recinella; Giustino Orlando; Claudio Ferrante; Annalisa Chiavaroli; Luigi Brunetti; Sheila Leone
Journal:  Front Physiol       Date:  2020-10-30       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.